| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/07391102.2012.726191 |
| P698 | PubMed publication ID | 23075283 |
| P2093 | author name string | Calvin Yu-Chian Chen | |
| Cheng-Chun Lee | |||
| Tung-Ti Chang | |||
| Mao-Feng Sun | |||
| Kuan-Chung Chen | |||
| Yi-Ru Jian | |||
| P2860 | cites work | I-TASSER: a unified platform for automated protein structure and function prediction | Q24605680 |
| Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose | Q24675630 | ||
| Structure validation by Calpha geometry: phi,psi and Cbeta deviation | Q27860657 | ||
| LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions | Q27861128 | ||
| The Sir2 family of protein deacetylases | Q28266179 | ||
| TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico | Q28476702 | ||
| Identification of potent EGFR inhibitors from TCM Database@Taiwan | Q28477481 | ||
| Identifying HER2 inhibitors from natural products database | Q28478359 | ||
| Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine | Q28478569 | ||
| In silico investigation of potential SRC kinase ligands from traditional Chinese medicine | Q28481644 | ||
| SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis | Q28583941 | ||
| Mammalian sirtuins: biological insights and disease relevance | Q29614496 | ||
| Screening from the world's largest TCM database against H1N1 virus | Q30399346 | ||
| High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database@Taiwan | Q30408391 | ||
| The Sir 2 family of protein deacetylases | Q33222287 | ||
| Three-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine. | Q34316470 | ||
| Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase | Q34628594 | ||
| Are sirtuins viable targets for improving healthspan and lifespan? | Q36385747 | ||
| NAD(+), sirtuins, and cardiovascular disease | Q37370477 | ||
| Sirtuins: a family of proteins with implications for human performance and exercise physiology | Q37831245 | ||
| Protective roles of SIRT1 in atherosclerosis. | Q37835642 | ||
| Sirt1's systemic protective roles and its promise as a target in antiaging medicine | Q37865873 | ||
| Can targeting SIRT-1 to treat type 2 diabetes be a good strategy? A review | Q38023959 | ||
| Novel cambinol analogs as sirtuin inhibitors: synthesis, biological evaluation, and rationalization of activity. | Q39856102 | ||
| Search for novel remedies to augment radiation resistance of inhabitants of Fukushima and Chernobyl disasters: identifying DNA repair protein XRCC4 inhibitors | Q41980724 | ||
| LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites | Q44247315 | ||
| Traditional Chinese medicine, a solution for reducing dual stroke risk factors at once? | Q45961690 | ||
| In silico pharmacology suggests ginger extracts may reduce stroke risks. | Q45961735 | ||
| Traditional Chinese medicine as dual guardians against hypertension and cancer? | Q47197241 | ||
| Lose weight with traditional chinese medicine? Potential suppression of fat mass and obesity-associated protein | Q47251605 | ||
| Investigation into potent inflammation inhibitors from traditional Chinese medicine | Q47278490 | ||
| iSMART: an integrated cloud computing web server for traditional Chinese medicine for online virtual screening, de novo evolution and drug design | Q47287940 | ||
| iScreen: world's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan | Q47291934 | ||
| Potent inhibitor design against H1N1 swine influenza: structure-based and molecular dynamics analysis for M2 inhibitors from traditional Chinese medicine database | Q47337151 | ||
| Sirt1's complex roles in neuroprotection | Q47745453 | ||
| A novel algorithm for identification of activated cryptic 5' splice sites. | Q51433900 | ||
| Mechanism of BAG1 repair on Parkinson's disease-linked DJ1 mutation. | Q52625121 | ||
| CHARMM: A program for macromolecular energy, minimization, and dynamics calculations | Q53340989 | ||
| Topology and dynamics of the interaction between 5-nitroimidazole radiosensitizers and duplex DNA studied by a combination of docking, molecular dynamic simulations and NMR spectroscopy | Q57964202 | ||
| P433 | issue | 11 | |
| P921 | main subject | traditional Chinese medicine | Q200253 |
| P304 | page(s) | 1207-1218 | |
| P577 | publication date | 2012-10-17 | |
| P1433 | published in | Journal of Biomolecular Structure and Dynamics | Q15754747 |
| P1476 | title | Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine | |
| P478 | volume | 31 |
| Q33747644 | Computational design of apolipoprotein E4 inhibitors for Alzheimer's disease therapy from traditional Chinese medicine. |
| Q33757779 | In Silico Identification of Potent PPAR-γ Agonists from Traditional Chinese Medicine: A Bioactivity Prediction, Virtual Screening, and Molecular Dynamics Study |
| Q33666808 | In silico design of BACE1 inhibitor for Alzheimer's disease by traditional Chinese medicine. |
| Q33876312 | In silico investigation of potential mTOR inhibitors from traditional Chinese medicine for treatment of Leigh syndrome |
| Q33766033 | Lead Screening for Chronic Obstructive Pulmonary Disease of IKK2 Inhibited by Traditional Chinese Medicine |
| Q30366183 | Lead discovery for Alzheimer's disease related target protein RbAp48 from traditional Chinese medicine. |
| Q33608964 | Potential Protein Phosphatase 2A Agents from Traditional Chinese Medicine against Cancer |
| Q33790946 | Potential mitochondrial isocitrate dehydrogenase R140Q mutant inhibitor from traditional Chinese medicine against cancers |
| Q33614602 | Potential retinoid x receptor agonists for treating Alzheimer's disease from traditional chinese medicine |
| Q34022289 | Potential smoothened inhibitor from traditional Chinese medicine against the disease of diabetes, obesity, and cancer |
| Q36615396 | Screening SIRT1 Activators from Medicinal Plants as Bioactive Compounds against Oxidative Damage in Mitochondrial Function |
| Q33746550 | Treatment of acute lymphoblastic leukemia from traditional chinese medicine |
| Q33876600 | Treatment of cardiovascular disease by traditional Chinese medicine against pregnane X receptor |
| Q88011656 | π-Cation Interactions in Molecular Recognition: Perspectives on Pharmaceuticals and Pesticides |
Search more.